Product Description:

• Gemcitabine is used to treat locally advanced or metastatic bladder cancer, in combination with cisplatin.
• Gemcitabine is used to treat locally advanced or metastatic pancreatic cancer.

How to use:

• Gemcitabine can only be prescribed by physicians with expertise in the use of anti-cancer drugs.
• Gemcitabine is well tolerated during infusion and the patient can walk (not lie down).

Caution & Warnings:

• Hematologic toxicity
• Liver failure and kidney failure
• Yellow fever vaccine and other live attenuated vaccines are not recommended for patients receiving gemcitabine
• the risk of cardiac and/or vascular disorders with gemcitabine
• Posterior reversible syndrome (PRES)
• Capillary leak syndrome
• pulmonary edema, interstitial pneumonia or severe adult respiratory distress syndrome (ARDS).
• spermatogenesis deficiency

Side Effects:

• nausea with/without vomiting, increased liver transaminases (AST/ALT) and alkaline phosphatase, occurring in approximately 60% of patients, proteinuria and hematuria occurring. in about 50% of patients; dyspnea in 10-40% of patients (highest rate in lung cancer patients); allergic skin rash occurs in about 25% of patients and is accompanied by pruritus in 10% of patients.

Ingredients:

• Gemcitabine 200Mg/20ml.